Precision Neuroscience Corp, a brain technology startup founded by Benjamin Rapoport, has raised $41M.  The firm will use the funds to advance its mission of creating brain implants to cure intractable diseases like epilepsy by accelerating the regulatory process.  Rapoport was the founding member of Elon Musk's brain computing interface company Neuralink.  He left Neuralink in 2018 and established Precision in 2021 along with private equity investor Michael Mager.  The startup is developing brain implants that can be placed on top of brain tissue without penetrating it.  Precision claims that its brain implants will be less invasive compared to Neuralink.  The New York-based startup has raised $12M in the past.  Forepont Capital Partners led the current funding round, joined by Mubadala Capital.  Brain-computing interface startups secured $274M in venture funding last year.